<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Lenalidomide is an immunomodulatory agent approved for use in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, and in combination with <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> for refractory or relapsed <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Pulmonary toxicity is believed to be uncommon </plain></SENT>
<SENT sid="2" pm="."><plain>In this report, we describe a patient receiving lenalidomide in whom <z:hpo ids='HP_0002094'>dyspnea</z:hpo>, <z:hpo ids='HP_0001945'>fever</z:hpo>, <z:mp ids='MP_0005039'>hypoxia</z:mp>, and diffuse <z:hpo ids='HP_0002113'>pulmonary infiltrates</z:hpo> developed </plain></SENT>
<SENT sid="3" pm="."><plain>BAL demonstrated a significant lymphocytic <z:mp ids='MP_0010922'>alveolitis</z:mp> typical for <z:hpo ids='HP_0006516'>hypersensitivity pneumonitis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Extensive workup for other causes, including <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>, was negative </plain></SENT>
<SENT sid="5" pm="."><plain>Finally, the patient had improvement in symptoms and oxygenation after withdrawing lenalidomide and recurrence of symptoms when the drug was restarted </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, the patient's clinical course and workup strongly support a diagnosis of lenalidomide-induced <z:hpo ids='HP_0006516'>hypersensitivity pneumonitis</z:hpo>-like syndrome </plain></SENT>
<SENT sid="7" pm="."><plain>Physicians should be cognizant of this potential complication in patients receiving thalidomide or thalidomide-like drugs who present with <z:hpo ids='HP_0001945'>fever</z:hpo> and <z:hpo ids='HP_0002113'>pulmonary infiltrates</z:hpo> and fail to improve despite treatment with broad-spectrum antibiotics </plain></SENT>
</text></document>